Phase I/II Trial rHuKFG for the Treatment of Steroid Refractory Gastrointestinal Acute GVHD

计划入组 7 人 · 首次发布于 2002 年 6 月 7 日

Budesonide for Prevention of Acute Gastrointestinal GVHD Following Allogenic Stem Cell Transplantation

计划入组 242 人 · 首次发布于 2005 年 9 月 16 日

5-Azacytidine With Steroids for Gastrointestinal GVHD (5-AZA FOR GVHD)

计划入组 20 人 · 首次发布于 2024 年 9 月 19 日

GVHD(TRx Biosciences)

gastrointestinal disease project

GPR35 inhibitor (gastrointestinal tumor/ gastrointestinal diseases/ulcerative colitis)

HOKKAIDO GASTROINTESTINAL CANCER STUDY GROUP

Japan

American Society For Gastrointestinal Endoscopy

United States

PRINCE OF WALES HOSPITAL

Australia

GvHD Pipeline 2026: Cell-Based, Microbiome and Targeted Therapies Reshape Treatment Landscape

Dana-Farber Researchers to Present Groundbreaking Cellular Therapy Studies at 2025 Tandem Meetings

MaaT Pharma's Microbiome Therapy Shows 62% Response Rate in Severe Graft-versus-Host Disease